REGENXBIO Inc.
RGNX
$6.34
$0.213.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.11% | -8.41% | 12.60% | -1,265.07% | 111.88% |
| Total Depreciation and Amortization | -0.31% | -0.44% | -0.49% | -1.26% | -1.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.00% | 2.59% | 23.60% | 40.49% | 84.93% |
| Change in Net Operating Assets | 16.51% | 82.65% | -237.58% | -54.07% | 40.79% |
| Cash from Operations | -45.70% | 6.56% | -13.41% | -246.72% | 206.34% |
| Capital Expenditure | -143.11% | -3.46% | -25.58% | 61.82% | 5.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.78% | -11.06% | 130.55% | -406.00% | 10.68% |
| Cash from Investing | 88.04% | -11.23% | 130.11% | -413.87% | 11.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 782.22% | -87.85% | 850.00% | -82.93% | 1,102.63% |
| Repurchase of Common Stock | -- | 100.00% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.63% | -25.62% | -105.53% | 2,523.86% | 26.19% |
| Cash from Financing | -42.31% | -35.31% | -105.09% | 2,503.04% | 25.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.95% | -17.25% | 58.94% | -169.64% | 7,884.38% |